Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

CMV pentamer complex proteins/gB-encoding mRNA vaccine mRNA-1647

A messenger RNA (mRNA) vaccine consisting of six mRNAs five of which encode the human cytomegalovirus (CMV) subunits that form the membrane-bound pentamer protein complex and one that encodes the full-length membrane-bound glycoprotein B (gB), with potential immunostimulatory activity against CMV. Upon intramuscular (IM) administration of the CMV pentamer complex proteins/gB-encoding mRNA vaccine mRNA-1647, the mRNAs are translated by the cellular protein translation machinery to produce the proteins. This exposes the immune system to the six peptides, activates both humoral and cellular immune responses, and may provide active immunization against both the pentamer proteins and gB and therefore against CMV infection. Both the pentamer, consisting of gH, gL, UL128, UL130 and UL131 proteins, and gB are essential for CMV to infect barrier epithelial surfaces. CMV can cause significant disease in immunocompromised patients.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:mRNA vaccine mRNA-1647
mRNA-based CMV vaccine mRNA-1647
Code name:mRNA 1647
mRNA-1647
mRNA1647
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search